CTOR — CITIUS ONCOLOGY INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 67.1% | -597.4% | — | — | — | — |
Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 22 SEC-registered investment managers reported holding CTOR (CITIUS ONCOLOGY INC) in their latest 13F filings, with a combined reported value of $13.88M across 13.74M shares. That is -4.1% by share count (-571.80K shares) versus the previous quarter, while reported value moved +49.0%. Ownership is concentrated: the five largest holders account for 95.9% of reported value and the top ten for 99.0%.
Compared with the prior quarter, 8 opened new positions, 3 added to existing stakes, 3 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CITIUS ONCOLOGY INC (CTOR) include Farallon Capital Management, D. E. Shaw & Co, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 41 institutional holders on this page.
CTOR is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 22 | 13.74M | $13.88M | -4.1% |
| Q2 2026 | 19 | 14.35M | $9.33M | -1.4% |
| Q1 2026 | 13 | 14.25M | $8.83M | +124.7% |
| Q4 2025 | 17 | 6.86M | $6.86M | -19.1% |
| Q3 2025 | 16 | 8.36M | $16.97M | +86.0% |
| Q2 2025 | 7 | 227.49K | $989.59K | +17.0% |
| Q1 2025 | 7 | 117.01K | $108.82K | +35.8% |
| Q4 2024 | 11 | 200.88K | $230.19K | +109.1% |
Over the 8 quarters shown, institutional share counts increased 6740% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+124.7%).
Top Institutional Holders (Q3 2026) — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.34M | $8.42M | 0.12% | Reduce | |
| 3.84M | $3.87M | 0.00% | Hold | |
| 546.33K | $551.79K | 0.00% | Hold | |
| 281.93K | $284.75K | 0.00% | Add | |
| 175.10K | $176.85K | 0.00% | Add | |
| 125.82K | $127.08K | 0.00% | Add | |
| 107.42K | $108.50K | 0.00% | Hold | |
| 107.42K | $108.50K | 0.09% | New | |
| 45.75K | $46.20K | 0.00% | Hold | |
| 42.90K | $43.33K | 0.00% | Hold | |
| 31.23K | $31.00K | 0.00% | New | |
| 25.00K | $25.25K | 0.00% | New | |
| 21.00K | $21.21K | 0.00% | New | |
| 13.98K | $14.12K | 0.00% | Reduce | |
| 13.03K | $13.16K | 0.00% | New | |
| 13.72K | $12.34K | 0.00% | New | |
| 10.60K | $10.71K | 0.00% | New | |
| 3.93K | $3.97K | 0.00% | Reduce | |
| 1.00K | $1.01K | 0.00% | Hold | |
| 500 | $505 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.71M | $5.66M | 0.07% | Reduce | |
| 3.84M | $2.49M | 0.00% | Hold | |
| 546.33K | $355.11K | 0.00% | Add | |
| 334.62K | $217.50K | 0.00% | Add | |
| 245.41K | $159.54K | 0.00% | New | |
| 245.41K | $159.54K | 0.00% | Reduce | |
| 121.91K | $79.24K | 0.00% | Hold | |
| 107.42K | $69.84K | 0.00% | Hold | |
| 90.59K | $58.89K | 0.00% | New | |
| 45.75K | $29.74K | 0.00% | Hold | |
| 21.88K | $14.00K | 0.00% | New | |
| 20.64K | $13.42K | 0.00% | New | |
| 13.82K | $8.98K | 0.00% | New | |
| 11.67K | $7.58K | 0.00% | Hold | |
| 1.00K | $650 | 0.00% | Reduce | |
| 500 | $325 | 0.00% | New | |
| 90 | $59 | 0.00% | New | |
| 23 | $15 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q1 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.19M | $5.70M | 0.11% | Add | |
| 3.84M | $2.37M | 0.00% | Add | |
| 534.82K | $331.59K | 0.00% | New | |
| 264.73K | $164.11K | 0.00% | Add | |
| 121.91K | $75.58K | 0.00% | New | |
| 107.42K | $66.59K | 0.00% | Add | |
| 47.45K | $29.42K | 0.00% | Add | |
| 45.75K | $28.36K | 0.00% | Hold | |
| 42.90K | $26.59K | 0.00% | Hold | |
| 36.84K | $22.84K | 0.00% | Add | |
| 11.67K | $7.23K | 0.00% | Hold | |
| 10.12K | $6.28K | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New |
Q4 2025 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.58M | $5.58M | 0.07% | Reduce | |
| 597.00K | $597.00K | 0.00% | Add | |
| 220.05K | $220.05K | 0.00% | Add | |
| 104.50K | $104.50K | 0.00% | New | |
| 87.42K | $87.42K | 0.00% | Add | |
| 73.99K | $73.99K | 0.00% | Reduce | |
| 45.75K | $45.75K | 0.00% | Add | |
| 42.90K | $42.90K | 0.00% | Hold | |
| 23.52K | $23.52K | 0.00% | New | |
| 22.34K | $22.34K | 0.00% | New | |
| 21.46K | $21.46K | 0.00% | Add | |
| 13.36K | $13.36K | 0.00% | New | |
| 11.67K | $11.67K | 0.00% | Hold | |
| 11.43K | $11.43K | 0.00% | Reduce | |
| 1.50K | $1.50K | 0.00% | New | |
| 214 | $214 | 0.00% | Reduce | |
| 3 | $3 | 0.00% | Hold |
Q3 2025 — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 7.68M | $15.58M | 0.23% | New | |
| 180.17K | $365.74K | 0.00% | New | |
| 167.17K | $339.36K | 0.00% | Add | |
| 126.88K | $257.57K | 0.01% | New | |
| 55.90K | $113.48K | 0.00% | New | |
| 42.90K | $87.09K | 0.00% | New | |
| 33.22K | $67.43K | 0.00% | Add | |
| 21.76K | $44.18K | 0.00% | New | |
| 17.66K | $35.85K | 0.00% | New | |
| 11.74K | $25.24K | 0.00% | Add | |
| 11.85K | $24.05K | 0.00% | New | |
| 11.67K | $23.68K | 0.00% | Hold | |
| 264 | $536 | 0.00% | Reduce | |
| 55 | $112 | 0.00% | Reduce | |
| 5 | $10 | 0.00% | New | |
| 3 | $6 | 0.00% | New |
Q2 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 106.97K | $465.32K | 0.00% | New | |
| 57.30K | $249.24K | 0.00% | Add | |
| 22.21K | $96.64K | 0.00% | Hold | |
| 15.42K | $67.09K | 0.00% | Reduce | |
| 11.67K | $50.75K | 0.00% | New | |
| 8.57K | $37.28K | 0.00% | Add | |
| 5.35K | $23.27K | 0.00% | Add |
New Positions (Q3 2026)
- PFS Signature Wealth LLC 107.42K sh · $108.50K
- HRT FINANCIAL LP 31.23K sh · $31.00K
- Private Advisor Group, LLC 25.00K sh · $25.25K
- CAPTRUST FINANCIAL ADVISORS 21.00K sh · $21.21K
- TWO SIGMA SECURITIES, LLC 13.03K sh · $13.16K
- StoneX Group Inc. 13.72K sh · $12.34K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 10.60K sh · $10.71K
- Citigroup Inc 1 sh · $1
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 245.41K sh · $159.54K
- Virtu Financial LLC sold 21.88K sh · $14.00K
- XTX Topco Ltd sold 20.64K sh · $13.42K
- Arkadios Wealth Advisors sold 11.67K sh · $7.58K
- BARCLAYS PLC sold 90 sh · $59
- Morgan Stanley sold 23 sh · $15
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.34M | 8.71M | 9.19M | 5.58M | 7.68M | — | — | — | — | — | — | — | — |
| Bank of America Corp | 3.84M | 3.84M | 3.84M | 214 | 264 | 8.57K | 160 | 160 | 160 | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 546.33K | 546.33K | 534.82K | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 281.93K | 245.41K | 264.73K | 220.05K | 167.17K | 57.30K | 20.54K | 12.65K | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 175.10K | 121.91K | 121.91K | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 125.82K | 90.59K | — | — | 17.66K | — | — | 22.70K | — | — | — | — | — |
| IFP Advisors, Inc | 107.42K | 107.42K | 107.42K | 87.42K | 33.22K | 22.21K | 22.21K | 22.21K | 8.13K | — | — | — | — |
| PFS Signature Wealth LLC | 107.42K | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 45.75K | 45.75K | 45.75K | 45.75K | 21.76K | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 42.90K | — | 42.90K | 42.90K | 42.90K | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 31.23K | — | — | — | — | — | — | 68.54K | — | — | — | — | — |
| Private Advisor Group, LLC | 25.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| CAPTRUST FINANCIAL ADVISORS | 21.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 13.98K | 334.62K | 36.84K | 21.46K | 55 | 15.42K | 49.74K | 24.80K | 1.63K | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | 13.03K | — | — | 13.36K | — | — | — | — | — | — | — | — | — |
| StoneX Group Inc. | 13.72K | — | — | — | — | — | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10.60K | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 3.93K | 13.82K | — | — | 11.85K | — | — | 41 | 41 | — | — | — | — |
| OSAIC HOLDINGS, INC. | 1.00K | 1.00K | 10.12K | 11.43K | 11.74K | 5.35K | 350 | 5.48K | 5.48K | — | — | — | — |
| Wells Fargo & Co | 500 | 500 | — | — | — | — | — | — | — | 2.02M | 2.02M | 2.02M | 2.02M |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CTOR?
As of 2026-Q3, 22 institutional funds reported holding CTOR (CITIUS ONCOLOGY INC) in SEC 13F filings, with a combined reported value of $13.88M.
How many shares of CTOR do institutions own?
13F filers reported 13.74M shares of CTOR, worth $13.88M in aggregate at the end of 2026-Q3.
Is institutional ownership of CTOR rising or falling?
Share counts moved -4.1% versus the prior quarter — distribution.
Who are the top institutional holders of CTOR?
The largest 13F holders are Farallon Capital Management, D. E. Shaw & Co, ARMISTICE CAPITAL, LLC, Bank of America Corp, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of CITIUS ONCOLOGY INC?
The major shareholders of CITIUS ONCOLOGY INC (CTOR) by reported 13F value are Farallon Capital Management, D. E. Shaw & Co, ARMISTICE CAPITAL, LLC, Bank of America Corp, Vanguard Group, among 41 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.